FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029750 [Registered on: 11/12/2020] Trial Registered Prospectively
Last Modified On: 07/08/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Relationship and differences between Central Aortic and Peripheral Blood Pressure measurement performed with the same device. 
Scientific Title of Study   Relationship and differences between Central Aortic and Peripheral Blood Pressure measurement performed with same device 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Dr Upendra Kaul  
Designation  Principal Investigator 
Affiliation  Batra Hospital & Medical Research Centre 
Address  1, Tughlakabad Institutional Area, Mehrauli Badarpur Road, New Delhi-110 062
1, Tughlakabad Institutional Area, Mehrauli Badarpur Road, New Delhi-110 062
New Delhi
DELHI
110062
India 
Phone  9811150518  
Fax    
Email  kaul.upendra@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nilesh Goswami  
Designation  Medical Specialist- Medical Affairs and Clinical Research 
Affiliation  Eris Lifesciences Ltd. 
Address  Department, 8th floor, commerce house IV, besides shell petrol pump, near Prahladnagar garden, 100 ft. road, satellite, Ahmedabad

Ahmadabad
GUJARAT
380015
India 
Phone  8291411412  
Fax    
Email  nilesh.goswami@erislifesciences.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nilesh Goswami  
Designation  Medical Specialist- Medical Affairs and Clinical Research 
Affiliation  Eris Lifesciences Ltd. 
Address  Department, 8th floor, commerce house IV, besides shell petrol pump, near Prahladnagar garden, 100 ft. road, satellite, Ahmedabad

Ahmadabad
GUJARAT
380015
India 
Phone  8291411412  
Fax    
Email  nilesh.goswami@erislifesciences.com  
 
Source of Monetary or Material Support  
Eris Lifesciences Ltd Department, 8th floor, commerce house IV, besides shell petrol pump, near Prahladnagar garden, 100 ft. road, satellite, Ahmedabad- 380015,GUJARAT, India  
 
Primary Sponsor  
Name  Eris Lifesciences Ltd  
Address  8th floor, commerce house IV, besides shell petrol pump, near Prahladnagar garden, 100 ft. road, satellite, Ahmadabad 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 7  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Abraham Oomman  Apollo Hospital Enterprise Limited  No.21, Greams Lane, Off Greams road, Chennai - 600006, Tamil Nadu
Chennai
TAMIL NADU 
9841174578

drabrahamoomman@gmail.com 
Prof Dr Upendra Kaul   Batra Hospital & Medical Research Centre  1, Tughlakabad Institutional Area, Mehrauli Badarpur Road, New Delhi-110 062
New Delhi
DELHI 
9811150518

kaul.upendra@gmail.com 
Prof Dr Gurpreet Singh Wander  HERO DMC Heart Institute, Dayanand Medical College & Hospital  Civil Lines, Tagore nagar, Ludhiana, Punjab 141001
Ludhiana
PUNJAB 
9815545316

drgswander@yahoo.com 
Dr Prof JC Mohan  Jaipur Golden Hospital  Street Number 2, near Institutional Area, Institutional Area, Sector 3, Rohini, Delhi, 110085
North West
DELHI 
9811061392

a51hauzkhas@gmail.com 
Dr Thomas Alexander  Kovai Medical Center and Hospital,   99, Avanashi Road, Coimbatore - 641014
Coimbatore
TAMIL NADU 
9791907685

tomalex41@gmail.com 
Dr PB Jayagopal  Laxmi Hospital  No. 17/551 chittur road, Palakkad, Kerala-678013
Palakkad
KERALA 
9847023777

jaigopallakshmi@gmail.com 
Dr JPS Sawhney  Sir Ganga Ram Hospital  Sarhadi Gandhi Marg, near Bal Bharati Public School, Old Rajinder Nagar, Rajinder Nagar, New Delhi, Delhi 110060
New Delhi
DELHI 
9810059773

jpssawhney@yahoo.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 4  
Name of Committee  Approval Status 
Ethics committee, Sir Ganga Ram Hospital  Approved 
Institutional Ethics Committee, Dayanand Medical College & Hospital  Submittted/Under Review 
Institutional Ethics Committee, King Georges Medical University  Submittted/Under Review 
Scientific research and ethic review committee (SRERC), Batra Hospital & Medical Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I10||Essential (primary) hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  1. Outpatients with hypertension (BP greater than 140/90 mm Hg or any level of blood pressure in persons on antihypertensive medications)
2. Newly Diagnosed Hypertensive Patients
3. Normotensive patients on antihypertensive
4. Hypertensive subjects with a family history of premature coronary heart disease
5. Hypertensive patients with comorbidities (Diabetes, Dyslipidaemia, CAD, left ventricular hypertrophy, peripheral arterial disease, cerebrovascular disease, microalbuminuria or proteinuria)
 
 
ExclusionCriteria 
Details  1. Subjects with evidence of recent event (MI < 1-month duration, treated angina at the time of enrolment, a cerebrovascular event in the 3 months before enrolment, heart failure, uncontrolled arrhythmias, or any clinically important haematological or biochemical abnormality on routine screening)
2. In-patients/Hospitalized patients
3. Pregnant Women
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To establish correlation and differences between brachial blood pressure and central blood pressure so as to establish the cut-off values (threshold values) for central blood pressure based on the brachial blood pressure.  1 Year 
 
Secondary Outcome  
Outcome  TimePoints 
To establish the correlation between CBP and BBP with organ damage (LV hypertrophy, End-stage kidney disease etc)   1 Year 
 
Target Sample Size   Total Sample Size="1200"
Sample Size from India="1200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Accumulating evidence indicates that central blood pressure (CBP) is a better cardiovascular risk predictor than brachial blood pressure (BBP). Although more additional benefits of CBP based treatment above usual hypertension treatment are to be demonstrated, the demand for implementing CBP assessment in general clinical practice is increasing. For this, the measurement procedure must be non-invasive, easy to perform, and cost- and time-efficient. Therefore, oscillometric devices with the possibility to assess CBP seem the best option 
Close